T. Rowe Price Associates’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $63K | Sell |
|
|||||
|
2023
Q1 | $86K | Buy |
|
|||||
|
2022
Q4 | $57K | Hold |
|
|||||
|
2022
Q3 | $153K | Sell |
|
|||||
|
2022
Q2 | $123K | Sell |
|
|||||
|
2022
Q1 | $86K | Buy |
|
|||||
|
2021
Q4 | $124K | Sell |
|
|||||
|
2021
Q3 | $419K | Buy |
|
|||||
|
2021
Q2 | $272K | Buy |
|
|||||
|
2021
Q1 | $341K | Sell |
|
|||||
|
2020
Q4 | $272K | Sell |
|
|||||
|
2020
Q3 | $274K | Hold |
|
|||||
|
2020
Q2 | $357K | Buy |
|
|||||
|
2020
Q1 | $261K | Buy |
|
|||||
|
2019
Q4 | $484K | Buy |
|
|||||
|
2019
Q3 | $400K | Buy |
|
|||||
|
2019
Q2 | $540K | Buy |
|
|||||
|
2019
Q1 | $354K | Buy |
|
|||||
|
2018
Q4 | $171K | Sell |
|
|||||
|
2018
Q3 | $341K | Buy |
|
|||||
|
2018
Q2 | $234K | Buy |
|
|||||
|
2018
Q1 | $300K | Buy |
|
|||||
|
2017
Q4 | $230K | Sell |
|
|||||
|
2017
Q3 | $412K | Buy |
|
|||||
|
2017
Q2 | $321K | Sell |
|
|||||
|
2017
Q1 | $414K | Hold |
|
|||||
|
2016
Q4 | $349K | Hold |
|
|||||
|
2016
Q3 | $367K | Hold |
|
|||||
|
2016
Q2 | $358K | Buy |
|
|||||
|
2016
Q1 | $388K | Hold |
|
|||||
|
2015
Q4 | $435K | Sell |
|
|||||
|
2015
Q3 | $833K | Buy |
|
|||||
|
2015
Q2 | $982K | Buy |
|
|||||
|
2015
Q1 | $541K | Sell |
|
|||||
|
2014
Q4 | $320K | Hold |
|
|||||
|
2014
Q3 | $167K | Buy |
|
|||||
|
2014
Q2 | $173K | Hold |
|
|||||
|
2014
Q1 | $197K | Hold |
|
|||||
|
2013
Q4 | $187K | Buy |
|